omniture
GUARDANT HEALTH PTE LTD

Latest News

Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa

PALO ALTO, Calif., Jan. 8, 2024 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading preci...

2024-01-08 15:30 1521

Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea

SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision on...

2023-11-13 08:00 2770

Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers

* Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical informa...

2023-05-30 09:00 2921

Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China

Collaboration will provide biopharmaceutical companies access to Guardant Health's broad portfolio ...

2022-07-06 18:17 3578

Guardant Health Receives Regulatory Approval for Guardant360 CDx in Japan

TOKYO, March 14, 2022 /PRNewswire/ -- The Ministry of Health, Labour and Welfare (MHLW) has granted...

2022-03-14 16:22 2306

Guardant360 CDx submitted for regulatory approval in Japan

TOKYO, Feb. 3, 2021 /PRNewswire/ -- Guardant Health Japan, an affiliate of Guardant Health Asia,Mid...

2021-02-03 18:41 2851

Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients

SINGAPORE, May 30, 2020 /PRNewswire/ -- According to the data presented at the American Society of ...

2020-05-30 19:00 3386